The Scottish Event Campus (SEC), Glasgow is set to welcome thousands of international allergy and immunology professionals 13-16 June it hosts the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025. EAACI 2025 will bring over 7,500 attendees to Glasgow, including leading scientists, clinicians, researchers, and healthcare professionals from more than 100 countries.
The 2025 edition will include the Clinical Allergy Village – a free, public-facing event at Glasgow Science Centre – offering residents, healthcare professionals, and students a chance to explore the latest in allergy treatment, prevention, and research.
A key theme of this year’s Congress is the growing impact of climate change on allergic and immunological diseases – from rising asthma rates to the lengthening of pollen seasons. Experts will examine how environmental shifts are driving the increased prevalence and severity of conditions such as hay fever, eczema, and food allergies, sharing the latest scientific insights and preventative strategies with both professional and public audiences.
María Torres, EAACI president, said: “By fostering dialogue across disciplines and regions, we accelerate progress for patients and shape a more resilient, sustainable future for healthcare.”
Kathleen Warden, director of Conference Sales at the SEC, added: “Our collaborative approach, working closely with EAACI, Glasgow Convention Bureau, and the wider city, ensures this event will leave a meaningful legacy, including improving awareness of the impact of climate change on wider health.”
Over its four-day run, EAACI 2025 is expected to deliver a significant economic benefit of £27m to Glasgow’s economy, £32m for Scotland and £54m for the UK.
